White House using Defense Production Act to equip Merck plants for Johnson & Johnson vaccine

March 2, 2021 Americas, CO, Company News, Coronavirus, DPA, General news, health, Major News, MERCK, North America, Pharmaceuticals (NEC) (TRBC level 5), Pharmaceuticals (TRBC level 3), Pharmaceuticals (TRBC level 4), Pharmaceuticals & Medical Research (TRBC level 2), Reuters Top News, united states, US, US Government News", Vaccines

White House press secretary Jen Psaki speaks during a briefing at the White House in Washington, U.S., March 2, 2021. REUTERS/Kevin Lamarque

NEW YORK (Reuters) – The United States is using the Defense Production Act to equip drugmaker Merck & Co’s plants to make Johnson & Johnson’s just approved COVID-19 vaccine, White House press secretary Jen Psaki said on Tuesday.

“As soon as we learned about the fact that Johnson and Johnson was behind in the manufacturing steps and efforts we took steps to ensure we can expedite that and partner them with one of the world’s biggest manufacturers,” Psaki told a White House briefing.

Source: Read Full Article

A bath could cause an uncomfortable infection – five warning signs

Older mothers who have C-section more likely to have complications

Breastfeeding may help protect mothers against stroke